re: marsbar Hey numbskull.
Recurring revenue some way off yes, but don't discount milestone payments due from Medtronic. I have a suspicion that cleverly when negotiations started over a year ago, XBL and Med merged the two technical teams so that if/when negotiations were completed they were already off to a running start on collaboration. So development is already basically a year ahead, and at each stage of development progress, XBL will get lumps of cash.
Not sure of background of ACU, but I like the look of it at the moment...
- Forums
- ASX - By Stock
- is it time for biotechs?
XBL
xceed biotechnology ltd
re: marsbar Hey numbskull.Recurring revenue some way off yes,...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XBL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online